Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.33696/immunology.4.128
Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau
Tyler C. Hammond1,2, Ai-Ling Lin1,3,4,*
- 1Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, US
- 2Department of Neuroscience, University of Kentucky, Lexington, KY, USA
- 3Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA
- 4Department of Radiology and Biological Sciences, University of Missouri, Columbia, MO, USA
Corresponding Author
Ai-Ling Lin, ai-ling.lin@health.missouri.edu
Received Date: October 06, 2021
Accepted Date: January 24, 2022
Citation:
Hammond TC, Lin A-L. Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau. J Cell Immunol. 2022;4(1):15-18
Copyright: © 2022 Hammond TC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.